Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etoricoxib in Primary Hypertrophic Osteoarthropathy
NCT02438709Phase 3Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Dec 2012
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of etoricoxib in primary hypertrophic osteoarthropathy (PHOA), sponsored by Peking Union Medical College Hospital. Status: unknown.
02
Drugs
etoricoxib
03
Conditions
primary hypertrophic osteoarthropathy (PHOA)
Beyond the preview
Go deeper on NCT02438709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02438709.